Anticorps Recombinant de lapin anti-RXRA

RXRA Recombinant Antibody for WB, IF/ICC, FC (Intra), ELISA, ChIP-qPCR

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, souris

Applications

WB, IF/ICC, FC (Intra), ELISA, ChIP-qPCR

Conjugaison

Non conjugué

Publications(1)

CloneNo.

240878A9

N° de cat : 83796-5-RR

Synonymes

ORF-3, 240878A9, NR2B1, ORF3, Retinoic acid receptor RXR-alpha



Applications testées

Résultats positifs en WBcellules HeLa, cellules COLO 320, cellules HepG2, cellules MCF-7, cellules NIH/3T3
Résultats positifs en IF/ICCcellules HeLa,
Résultats positifs en FC (Intra)cellules MCF-7,
Résultats positifs en ChIP-qPCRcellules HepG2,

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:2000-1:10000
Immunofluorescence (IF)/ICCIF/ICC : 1:300-1:1200
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
CHImmunoprécipitation (IP)-QPCRCHIP-QPCR : 1:10-1:100
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Applications publiées

WBSee 1 publications below

Informations sur le produit

83796-5-RR cible RXRA dans les applications de WB, IF/ICC, FC (Intra), ELISA, ChIP-qPCR et montre une réactivité avec des échantillons Humain, souris

Réactivité Humain, souris
Réactivité citéeHumain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène RXRA Protéine recombinante Ag15651
Nom complet retinoid X receptor, alpha
Masse moléculaire calculée 462 aa, 51 kDa
Poids moléculaire observé54 kDa, 44 kDa
Numéro d’acquisition GenBankBC110998
Symbole du gène RXRA
Identification du gène (NCBI) 6256
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

Retinoid X receptor alpha (RXRA). Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high-affinity ligand for RXRs is 9-cis retinoic acid. RXRA serves as a common heterodimeric partner for a number of nuclear receptors. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of a ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation, and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes. This antibody is a rabbit polyclonal antibody raised against the 350 AA of human RXRA C-terminal. RXRA is highly expressed in the liver and also expressed in the lungs, kidneys, and heart. It can recognize the mature 54 kDa RXRA and the truncated 44 kDa RXRA (PMID: 20541701).

Protocole

Product Specific Protocols
WB protocol for RXRA antibody 83796-5-RRDownload protocol
IF protocol for RXRA antibody 83796-5-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Front Pharmacol

Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells

Authors - Ye Yang
{{ptg:RelatedPrimaryAntibodies}}